Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Clinical Pharmacology in Diuretic UseClinical journal of the American Society of Nephrology, 2019-08, Vol.14 (8), p.1248-1257 [Peer Reviewed Journal]Copyright © 2019 by the American Society of Nephrology 2019 ;ISSN: 1555-9041 ;EISSN: 1555-905X ;DOI: 10.2215/CJN.09630818 ;PMID: 30936153Full text available |
|
2 |
Material Type: Article
|
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trialsThe Lancet (British edition), 2022-02, Vol.399 (10326), p.741-755 [Peer Reviewed Journal]2022 Elsevier Ltd ;Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)00018-6 ;PMID: 35085503Full text available |
|
3 |
Material Type: Article
|
In situ click chemistry generation of cyclooxygenase-2 inhibitorsNature communications, 2017-02, Vol.8 (1), p.1-14, Article 1 [Peer Reviewed Journal]Copyright Nature Publishing Group Feb 2017 ;The Author(s) 2017 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-016-0009-6 ;PMID: 28232747Full text available |
|
4 |
Material Type: Article
|
KESTREL and KITE: 52-Week Results From Two Phase III Pivotal Trials of Brolucizumab for Diabetic Macular EdemaAmerican journal of ophthalmology, 2022-06, Vol.238, p.157-172 [Peer Reviewed Journal]2022 ;Copyright © 2022. Published by Elsevier Inc. ;Copyright Elsevier Limited Jun 2022 ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2022.01.004 ;PMID: 35038415Full text available |
|
5 |
Material Type: Article
|
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular EdemaThe New England journal of medicine, 2015-03, Vol.372 (13), p.1193-1203 [Peer Reviewed Journal]Copyright © 2015 Massachusetts Medical Society. All rights reserved. ;Copyright © 2015 Massachusetts Medical Society. 2015 ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1414264 ;PMID: 25692915Full text available |
|
6 |
Material Type: Article
|
Pharmacology of Corticosteroids for Diabetic Macular EdemaInvestigative ophthalmology & visual science, 2018-01, Vol.59 (1), p.1-12 [Peer Reviewed Journal]Copyright 2018 The Authors 2018 ;ISSN: 1552-5783 ;ISSN: 0146-0404 ;EISSN: 1552-5783 ;DOI: 10.1167/iovs.17-22259 ;PMID: 29297055Full text available |
|
7 |
Material Type: Article
|
Effect of Intravitreous Anti–Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy: The Protocol W Randomized Clinical TrialArchives of ophthalmology (1960), 2021-07, Vol.139 (7), p.701 [Peer Reviewed Journal]Copyright American Medical Association Jul 2021 ;ISSN: 2168-6165 ;EISSN: 1538-3601 ;DOI: 10.1001/jamaophthalmol.2021.0606Full text available |
|
8 |
Material Type: Article
|
Concurrent Dexamethasone Limits the Clinical Benefit of Immune Checkpoint Blockade in GlioblastomaClinical cancer research, 2021-01, Vol.27 (1), p.276-287 [Peer Reviewed Journal]2020 American Association for Cancer Research. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.ccr-20-2291 ;PMID: 33239433Full text available |
|
9 |
Material Type: Article
|
Safety and efficacy of intravenous glyburide on brain swelling after large hemispheric infarction (GAMES-RP): a randomised, double-blind, placebo-controlled phase 2 trialLancet neurology, 2016-10, Vol.15 (11), p.1160-1169 [Peer Reviewed Journal]Elsevier Ltd ;2016 Elsevier Ltd ;Copyright © 2016 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Oct 01, 2016 ;ISSN: 1474-4422 ;EISSN: 1474-4465 ;DOI: 10.1016/S1474-4422(16)30196-X ;PMID: 27567243 ;CODEN: LANCAOFull text available |
|
10 |
Material Type: Article
|
Early and Long-term Responses to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema: Analysis of Protocol I DataAmerican journal of ophthalmology, 2016-12, Vol.172, p.72-79 [Peer Reviewed Journal]2016 The Authors ;Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Dec 01, 2016 ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2016.09.012 ;PMID: 27644589 ;CODEN: AJOPAAFull text available |
|
11 |
Material Type: Article
|
Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working GroupEye (London), 2020-06, Vol.34 (Suppl 1), p.1-51 [Peer Reviewed Journal]The Author(s), under exclusive licence to The Royal College of Ophthalmologists 2020. ;The Author(s), under exclusive licence to The Royal College of Ophthalmologists 2020 ;ISSN: 0950-222X ;EISSN: 1476-5454 ;DOI: 10.1038/s41433-020-0961-6 ;PMID: 32504038Full text available |
|
12 |
Material Type: Article
|
Skin-on-a-chip model simulating inflammation, edema and drug-based treatmentScientific reports, 2016-11, Vol.6 (1), p.37471, Article 37471 [Peer Reviewed Journal]Copyright Nature Publishing Group Nov 2016 ;Copyright © 2016, The Author(s) 2016 The Author(s) ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/srep37471 ;PMID: 27869150Full text available |
|
13 |
Material Type: Article
|
Visual acuity outcomes and anti-VEGF therapy intensity in diabetic macular oedema: a real-world analysis of 28 658 patient eyesBritish journal of ophthalmology, 2021-02, Vol.105 (2), p.216-221 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 ;ISSN: 0007-1161 ;EISSN: 1468-2079 ;DOI: 10.1136/bjophthalmol-2020-315933 ;PMID: 32265201Full text available |
|
14 |
Material Type: Article
|
Icariin modulates carrageenan-induced acute inflammation through HO-1/Nrf2 and NF-kB signaling pathwaysBiomedicine & pharmacotherapy, 2019-12, Vol.120, p.109567, Article 109567 [Peer Reviewed Journal]2019 The Author(s) ;Copyright © 2019 The Author(s). Published by Elsevier Masson SAS.. All rights reserved. ;ISSN: 0753-3322 ;EISSN: 1950-6007 ;DOI: 10.1016/j.biopha.2019.109567 ;PMID: 31670031Full text available |
|
15 |
Material Type: Article
|
Association of Predominantly Peripheral Lesions on Ultra-Widefield Imaging and the Risk of Diabetic Retinopathy Worsening Over TimeArchives of ophthalmology (1960), 2022-10, Vol.140 (10), p.946 [Peer Reviewed Journal]Copyright American Medical Association Oct 2022 ;ISSN: 2168-6165 ;EISSN: 1538-3601 ;DOI: 10.1001/jamaophthalmol.2022.3131Full text available |
|
16 |
Material Type: Article
|
Ranibizumab 0.5 mg treat-and-extend regimen for diabetic macular oedema: the RETAIN studyBritish journal of ophthalmology, 2016-06, Vol.100 (6), p.787-795 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Copyright: 2016 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ 2016 ;ISSN: 0007-1161 ;EISSN: 1468-2079 ;DOI: 10.1136/bjophthalmol-2015-307249 ;PMID: 26453639 ;CODEN: BJOPALFull text available |
|
17 |
Material Type: Article
|
Enhancement of Hematoma Clearance With CD47 Blocking Antibody in Experimental Intracerebral HemorrhageStroke (1970), 2019-06, Vol.50 (6), p.1539-1547 [Peer Reviewed Journal]2019 American Heart Association, Inc. ;ISSN: 0039-2499 ;EISSN: 1524-4628 ;DOI: 10.1161/STROKEAHA.118.024578 ;PMID: 31084334Full text available |
|
18 |
Material Type: Article
|
Association of Ultra-Widefield Fluorescein Angiography–Identified Retinal Nonperfusion and the Risk of Diabetic Retinopathy Worsening Over TimeArchives of ophthalmology (1960), 2022-10, Vol.140 (10), p.936 [Peer Reviewed Journal]Copyright American Medical Association Oct 2022 ;ISSN: 2168-6165 ;EISSN: 1538-3601 ;DOI: 10.1001/jamaophthalmol.2022.3130Full text available |
|
19 |
Material Type: Article
|
Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study): A 12-month, randomized, controlled, double-masked, multicenter phase II studyDiabetes care, 2010-11, Vol.33 (11), p.2399-2405 [Peer Reviewed Journal]2015 INIST-CNRS ;COPYRIGHT 2010 American Diabetes Association ;Copyright American Diabetes Association Nov 2010 ;2010 by the American Diabetes Association. ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc10-0493 ;PMID: 20980427 ;CODEN: DICAD2Full text available |
|
20 |
Material Type: Article
|
NSAIDs and Corticosteroids for the Postoperative Management of Age-Related Cataract Surgery: A Systematic Review and Meta-analysisAmerican journal of ophthalmology, 2024-04, Vol.260, p.1-13 [Peer Reviewed Journal]2023 Elsevier Inc. ;Copyright © 2023 Elsevier Inc. All rights reserved. ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2023.09.027 ;PMID: 37797866Full text available |